Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

DXCM

DEXCOM INC

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1093557Held by 6 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$4.66B
Net Income FY2025
$0.84B
EPS (Basic, as reported)
$2.14
Net Margin FY2025
17.9%
ROE FY2025
30.5%
Total Equity
$2.75B
Shares Out
377M
Business description

DEXCOM INC — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 573 → 4,662 +26.2% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021⚑FY2022FY2023FY2024FY2025
Revenue5737191,0321,4761,9272,4492,9103,6224,0334,662
Cost of revenue(195)(226)(368)(544)(647)(768)(1,027)(1,333)(1,595)(1,860)
Gross profit3784926649321,2801,6811,8832,2892,4382,802
Research & development(156)(185)(200)(273)(360)(517)(484)(506)(552)(599)
Selling, general & administrative(286)(349)(433)(516)(621)(810)(1,000)(1,185)(1,286)(1,291)
Total operating expenses(442)(535)(850)(789)(981)(1,415)(1,492)(1,691)(1,838)(1,890)
Operating income(64)(42)(186)142300266391598600912
Interest expense(1)(13)(23)(60)(85)(100)(19)(20)(19)(18)
Interest & investment income03———224135134113
Other income (expense), net(1)322616(2)18113109177
Pre-tax income(65)(49)(126)1042251743917107091,088
Income tax expense(1)(2)(1)(3)(269)(19)(50)(169)(133)(252)
Net income(66)(50)(127)101494155341542576836
EPS — basic—($0.58)($1.44)$1.11$5.23$1.60$0.88$1.40$1.46$2.14
EPS — diluted—($0.58)($1.44)$1.10$5.06$1.55$0.82$1.30$1.42$2.09
Shares outstanding — basic (M)—8688919497389386394390
Shares outstanding — diluted (M)—86889298100428426413406

Showing the latest 10 of 17 fiscal years.

  • ⚑ Weighted-average shares changed ×4.01 between FY2021 and FY2022 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.